Furthermore, an in vitro study demonstrated that elevated serotonin levels activated 5-HT2A receptors expressed in cardiomyocytes to worsen cardiac hypertrophy through the transient receptor potential canonical 1 (TRPC1) channel and calcineurin/NFAT signalling pathway10,11. Here, TRPC1 is linked to cardiac hypertrophy.